Home > News > Immunicon Announces Agreements with R&D Systems
August 19th, 2003
Immunicon Announces Agreements with R&D Systems
Abstract:
Immunicon Corporation today announced the completion of a non-exclusive license and supply agreement with R&D Systems, Inc. of Minneapolis, MN. In addition, under the terms of a separate agreement, R&D Systems, a wholly-owned subsidiary of Techne Corporation made an equity investment in Immunicon. Under the license and supply agreement, R&D Systems will use Immunicon's magnetic nano-particle cell isolation technology in conjunction with their reagents to develop products for life science research. (PDF)
Source:
PRNewswire
Bookmark:
| Related News Press |
Nanomedicine
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Good as gold - improving infectious disease testing with gold nanoparticles April 5th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||